Plasma neurotransmitters and functional illness

Psychotherapy and Psychosomatics

Volumn 65, Issue 6, 1996, Pages 293-318

  Lechin, Fuad ^a,c   Van Dijs, Bertha Der ^a   Lechin, Marcel E ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE   (Venezuela)

Author keywords

Adrenaline; Dopamine; Edinephrine; Functional illness; Neurotransmitters; Noradrenaline; Norepinephrine; Psychosomatic diseases; Psychosomatic disorders; Serotonin; Somatization; Stress

Indexed keywords

ADRENALIN; DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ADRENAL CELL; BLOOD BRAIN BARRIER; ENTEROCHROMAFFIN CELL; FUNCTIONAL DISEASE; MAST CELL; NERVE CELL; PSYCHOSOMATIC DISORDER; REVIEW;

EID: 0029849476     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000289090     Document Type: Review

References (204)

1. Fava A: The concept of psychosomatic disorder. Psychother Psychosom 1992;58:1-12.
2. Lipowski ZJ: Somatization. Psychother Psychosom 1987;47:160-167.
3. Cassileth BR, Drossman DA: Psychosocial factors in gastrointestinal illness. Psychother Psychosom 1993;59:131-143.
4. Kellner R: Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994;61:4-24.
5. Lechin F. van der Dijs B, Bentolila A, Peña F: The spastic colon syndrome: Therapeutic and pathophysiologic considerations. J Clin Pharmacol 1977;17:431-440.
6. Gershon MD: The enteric nervous system: An apparatus for intrinsic control of gastrointestinal motility. Viewpoints Dig Dis 1981;13:13-16.
7. Havanka-Kanniainen H, Tolonen U, Myllyla VV: Autonomic dysfunction in adult migraineurs. Headache 1986;26:425-433.
8. Hsu LKG, Crisp AH, Kalucy RS, Koval J, Chen CN, Carruthers M, Zilkha KJ: Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and the sleeping encephalographs of subjects experiencing early morning migraine; in Greene R (ed): Current Concepts in Migraine Research. New York, Raven Press, 1978, pp 121-130.
9. Anthony M: Biochemical indices of sympathetic activity in migraine. Cephalalgia 1981;1:83-89.
10. Schoenen J, de Noordhout AM, Delwaide PJ: Plasma catecholamines in headache patients, clinical correlations; in Olesen J, Schoenen J (eds): Headache 1985. Proc 2nd Int Headache Congr. Copenhagen, Stougaard Jensen, 1985, pp 23-24.
11. Gotoh F, Komatsumoto S, Araki N, Gomi S: Noradrenergic nervous activity in migraine. Arch Neurol 1984;41:951-955.
12. Fanciullacci M: Iris adrenergic impairment of idiopathic headache. Headache 1979;19:8-13.
13. Rubin LS, Graham D, Pasker R, Calhaun W: Autonomic nervous system dysfunction in common migraine. Headache 1985;25:40-48.
14. Fog-Moller F, Genefke IK, Bryndum B: Changes in concentration of catecholamines in blood during spontaneous migraine attacks and reserpine-induced attacks; in Greene R (ed): Curr Concepts Migraine Res. New York, Raven Press, 1978, pp 115-119.
15. Hanington E: The platelet and migraine. Headache 1986;26:411-415.
16. Anthony M, Lance JW: Histamine and serotonin in cluster headache. Arch Neurol 1971;25: 225-229.
17. Anthony M, Lance JW: Platelet serotonin in patients with chronic tension headaches. J Neurol Neurosurg Psychiatry 1989;52:182-184.
18. Anthony M: Mechanisms of platelet 5-hydroxytryptamine release in migraine. Conf Platelet Aggregation Pathogenesis Cerebrovasc Disord. Rome 1974.
19. Curran DA, Hinterberger H, Lance JW: Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxy mandelic acid excretion in normal and migrainous subjects. Brain 1965;88:997-1000.
20. Dexter JD, Weitzman DE: Neurology 1970;20: 513 (quoted by Hsu LKG, Crisp AH, Kalucy RS, Koval J, Chen CN, Carruthers M, Zilkha KJ: Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and the sleeping encephalographs of subjects experiencing early morning migraine: in Greene R (ed): Curr Concepts Migraine Res. New York, Raven Press, 1978, pp 121-130
21. Dexter JD, Weitzman DE: Neurology 1970;20: 513 (quoted by Hsu LKG, Crisp AH, Kalucy RS, Koval J, Chen CN, Carruthers M, Zilkha KJ: Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and the sleeping encephalographs of subjects experiencing early morning migraine: in Greene R (ed): Curr Concepts Migraine Res. New York, Raven Press, 1978, pp 121-130
22. Van der Dijs B, Lechin A, Villa S, Gomez F, Cabrera A, Jimenez V, Guerrero H, Lechin F: Plasma neurotransmitters profile in cluster headache. 3rd Interam Congr Clin Pharmacol Ther and 12th Latinam Congr Pharmacol, Caracas 1988. Arch Ven Farm Terap 1988; 7(suppl 1):3A.
23. Biondi M, Portuesi G: Tension-type headache: Psychosomatic clinical assessment and treatment. Psychother Psychosom 1994;61:41-64.
24. Takeshima T, Shimomura T, Takahashi K: Platelet activation in muscle contraction headache and migraine. Cephalalgia 1987;7:239-243.
25. Hannah P, Jarman J, Glover V, Sandler M, Davies PTG, Clifford RF: Kinetics of platelet 5-hydroxytryptamine uptake in headache patients. Cephalalgia 1991;11:141-145.
26. Rolf LH, Wiele G, Brune GG: 5-Hydroxytryptamine in platelets of patients with muscle contraction headache. Headache 1981;21:10-11.
27. Lechin ME, Jara H, Villa S, Gomez F, Jimenez V, Cabrera A, van der Dijs B, Lechin F: Plasma neurotransmitters in tension headache. 3rd Interam Congr Clin Pharmacol Ther and 12th Latinam Congr Pharmacol, Caracas 1988. Arch Ven Farm Terap 1988;7(suppl 1):1A.
28. Lechin F, van der Dijs B, Amat J, Lechin AE, Cabrera A, Lechin ME, Gomez F, Arocha L, Jimenez V: Definite and sustained improvement with pimozide of two patients with severe trigeminal neuralgia: Some neurochemical, neurophysiological and neuroendocrinological findings. 3rd Interam Congr Clin Pharmacol Ther and 12th Latinam Congr Pharmacol, Caracas 1988. Arch Ven Farm Terap 1988; 7(suppl 1):108A.
29. Lechin F, van der Dijs B, Amat J, Lechin AE, Lechin ME: Definite and sustained improvement with pimozide of two patients with severe trigeminal neuralgia: Some neurochemical, neurophysiological and neuroendocrinological findings. J Med 1988;19:243-256.
30. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, Gomez F, Acosta E, Arocha L, Villa S, Jimenez V: Pimozide therapy for trigeminal neuralgia. Arch Neurol 1989; 46:960-963.
31. Lechin F, van der Dijs B, Lechin AE, Orozco B, Lechin ME, Baez S, Rada Y, Leon G, Acosta E: Plasma neurotransmitters and cortisol in chronic illness: Role of stress. J Med 1994;25: 181-192.
32. Marks V: Functional hypoglycemia: Fact or fancy; in Andrea D, Marks V, Lefebvre PJ (eds): Hypoglycemia. New York, Raven Press, 1987. vol 38, pp 1-17.
33. Marks V: Glycemic stability in healthy subjects: Fluctuations in blood glucose concentration during the day; in Andrea D, Marks V, Lefebvre PJ (eds); Hypoglycemia. New York, Raven Press, 1987, vol 38, pp 19-24.
34. Fajans SS: Classification of 'functional hypoglycemia'; in Andrea D, Marks V, Lefebvre PJ (eds): Hypoglycemia. New York, Raven Press, 1987, vol 38, pp 25-33.
35. Cryer PE: Postprandial glucose counterregulation; in Andreani D, Marks V, Lefebvre PJ (eds): Hypoglycemia. New York, Raven Press, 1987, vol 38, pp 35-43.
36. Hofeldt FD: Functional hypoglycemia: Practical assessment; in Andreani D, Marks V, Lefebvre PJ (eds): Hypogiycemia. New York, Raven Press, 1987, vol 38, pp 55-62.
37. Fisher BM, Gray CE, Beastall GH, Frier BM: Evidence for multiple counterregulatory hormonal deficiences and dysfunction of the hypothalamic-pituitary axis in response to hypoglycemia in insulin dependent diabetes; in Andreani D, Marks V, Lefebvre PJ (eds): Hypoglycemia. New York, Raven Press, 1987, vol 38, pp 261-263.
38. Lechin F, van der Dijs B, Lechin A, Lechin M, Coll-Garcia E, Jara H, Cabrera A, Jimenez V, Gomez F, Tovar D, Rada Y, Arocha L: Doxepin therapy for postprandial symptomatic hypoglycemic patients: Neurochemical, hormonal and metabolic disturbances. Clin Sci 1991; 80:373-384.
39. Luck P, Mikhailidis DP, Dashwood MR, Barradas MA, Sever PS, Daadona P, Wakeling A: Platelet hyperaggregability and increased alpha-adrenoceptor density in anorexia nervosa. J Clin Endocrinol Metab 1983;57:911-914.
40. Nudel DB, Gootman N, Nussbaum MP, Shenker IR: Altered exercise performance and abnormal sympathetic responses to exercise in patients with anorexia nervosa. J Pediatr 1984; 105:34-37.
41. Heufelder A, Warnhoff M, Pirke KM: Platelet alphal-adrenoceptor and adenylate cyclase in patients with anorexia nervosa and bulimia. J Clin Endocrinol Metab 1985;61:1053-1060.
42. Waller DA, Gullion CM, Petty F, Hardy BW, Murdock MV, Rush AJ: Tridimensional personality questionnaire and serotonin in bulimia nervosa. Psychiatry Res 1993;48:9-15.
43. Buckholtz NS, George DT, Davies AO, Jimerson DC, Potter WZ: Lymphocyte beta-adrenergic receptor modification in bulimia. Arch Gen Psychiatry 1988;45:479-482.
44. George DT, Kaye WH, Goldstein DS, Brewerton TD, Jimerson DC: Altered norepinephrine regulation in bulimia: Effects of pharmacological challenge with isoproterenol. Psychiatry Res 1990;33:1-10.
45. Obarzanek E, Lesem MD, Jimerson DC: Resting metabolic rate of anorexia nervosa patients during weight gain. Am J Clin Nutr 1994;60: 666-675.
46. Cignarelli M, De Pergola G, Garruti G, Corso M, Cospite MR, Paternostro A, Romanazzi V, Giorgino R: Changes in overall plasma norepinephrine turnover and lymphocyte beta-adrenoceptor number during combined caloric and sodium restriction in normotensive obese subjects. Int J Obes 1990;14:429-437.
47. Gustafson AB, Farrell PA, Kalkhoff RK: Impaired plasma catecholamines response to submaximal treadmill exercise in obese women. Metabolism 1990;39:410-417.
48. Schwartz RS, Jaeger LF, Veith RC, Lakshminarayan S: The effects of diet or exercise on plasma norepinephrine kinetics in moderately obese young men. Int J Obes 1990;14:1-11.
49. Astrup A, Andersen T, Christensen NJ, Bulow J, Madsen J, Breum L, Quaade F: Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans. Am J Clin Nutr 1990;41:331-337.
50. Berlin I, Berlan M, Crespo-Laumonnier B, Landault C, Payan C, Puech AJ, Turpin G: Alterations in beta-adrenergic sensitivity and platelet alphal-adrenoceptors in obese women: Effect of exercise and caloric restriction. Clin Sci 1990;78:81-87.
51. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989;321:580-585.
52. Kush RD, Young JB, Katzeff HL, Danforth E Jr, Garrow JS, Scheidegger K, Ravussin E, Howard BV, Sims EA, Horton ES: Effect of diet on energy expenditure and plasma norepinephrine in lean and obese Pima indians. Metabolism 1986;35:1110-1120.
53. Yale JF, Leiter LA, Marliss EB: Metabolic responses to intense exercise in lean and obese subjects. J Clin Endocrinol Metab 1989;68: 438-445.
54. Giugliano D, Cozzolino D, Salvatore T, Torella R, Franchimont P, D'Onofrio F, Lefebvre PJ: Altered metabolic and hormonal responses to epinephrine and beta-endorphins in human obesity. J Clin Endocrinol Metab 1988;67: 238-244.
55. Dornfeld LP, Maxwell MH, Waks A, Tuck M: Mechanisms of hypertension in obesity. Kidney Int Suppl 1987;22:254-258.
56. Peterson HR, Rotschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA: Body fat and the activity of the autonomic nervous system. N Engl J Med 1988;318:1077-1083.
57. Hendler RG, Walesky M, Sherwin RS: Sucrose substitution in prevention and reversal of the fall in metabolic rate accompanying hypocaloric diets. Am J Med 1986;81:280-284.
58. DeHaven J, Sherwin R, Hendler R, Felig P: Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet. N Engl J Med 1980;302:477-482.
59. Blum Y, Nessiel L, Graff E, Harsat A, Gabbay U, Sulkes J, Raz O, Vered Y: Food preferences, body weight, and platelet-poor plasma serotonin and catecholamines. Am J Clin Nutr 1993; 57:486-489.
60. Ziegler MG, Lake CR, Kopin IJ: Plasma noradrenaline increases with age. Nature 1976; 261:333-336.
61. Raskind MA, Peskind ER, Veith RC, Beard JC, Gumbrecht G, Halter JB: Increased plasma and cerebrospinal fluid norepinephrine in older men: Differential suppression by clonidine. J Clin Endocrinol Metab 1988;66:438-442.
62. Young JB, Rowe JW, Pallotta JA, Sparrow D, Landsberg L: Enhanced plasma norepinephrine response to upright posture and oral glucose administration in elderly human subjects. Metabolism 1980;29:532-535.
63. Lehmann M, Keul J: The age- and training-dependent effects of physical work on plasma catecholamines and lactate acidosis. Dtsch Z Sportmed 1981;12:320-324.
64. Lake CR, Ziegler MG, Coleman MD, Kopin IJ: Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 1977;296:208-210.
65. Chen M, Halter JB, Porte D Jr: Plasma catecholamines, dietary carbohydrate, and glucose intolerance: A comparison between young and old men. J Clin Endocrinol Metab 1988;62: 1193-1195.
66. Sowers JR, Rubenstein LZ, Stern N: Plasma norepinephrine responses to posture and isometric exercise increase with age in the absence of obesity. J Gerontol 1983;38:315-318.
67. Barnes RM, Raskind M, Halter J, Gumbrecht G: The effects of age on the plasma catecholamine response to mental stress in man. J Clin Endocrinol Metab 1982;54:64-66.
68. Minaker KL, Rowe JW, Young JB, Sparrow D, Pallotta JA, Landsberg L: Effect of age on insulin stimulation of sympathetic nervous system activity in man. Metabolism 1982;31:1181-1183.
69. Fleg JL, Tzankoff SP, Lakatta EG: Age-related augmentation of plasma catecholamine during dynamic exercise in healthy males. J Appl Physiol 1985;59:1033-1036.
70. McCarty R: Age-related alterations in sympathetic-adrenal medullary responses to stress. Gerontology 1986;32:172-175.
71. Bertel O, Buhler FR, Kiowsski W, Iutold BE: Decreased beta-adrenoceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980;2:130-135.
72. Lechin F, van der Dijs B, Lechin ME, Jara H, Lechin AE, Baez S, Orozco B, Rada Y, Cabrera A, Arocha L, Jimenez V, Leon G: Plasma neurotransmitters throughout an oral glucose tolerance test in nondepressed essential hypertension patients. Clin Exp Hypertens 1993;15: 209-240.
73. Robertson D, Shand DG, Hollifeld JW, Nies AS, Frolich JC, Oates JA: Alterations in the response of the sympathetic nervous system and renin in borderline hypertension. Hypertension 1979;1:118-124.
74. Rados JP, Juhos E, Dorhout Meed EJ: Renal response to graded intravenous hypertonic NaCl infusion in healthy and hypertensive subjects: Dose-related impairment in distal NaCl reabsorption. Am Heart J 1980;100:183-189.
75. Shannon RP, Wei JY, Rosa RM, Epstein FH, Rowe JW: The effect of age and sodium depletion on cardiovascular response to orthostasis. Hypertension 1986;8:438-441.
76. Morganti A, Lopez-Overjero JA, Laragh JH: Role of the sympathetic nervous system in mediating the renin response to head-up tilt. Am J Cardiol 1979;43:600-604.
77. Morganti A, Pickering TG, Lopez-Overjero JA, Laragh JH: High and low renin subgroups of essential hypertension: Differences and similarities in their renin and sympathetic responses to neural and non-neural stimuli. Am J Cardiol 1980;46:306-312.
78. Wang PC, Buu NT, Kuchel O, Genest J: Conjugation patterns of endogenous plasma catecholamines in human and rat. A new specific method for analysis of glucuronide-conjugated catecholamines. J Lab Clin Med 1983;101:141-144.
79. Lockhandwala MF, Hedge SS: Cardiovascular dopamine receptors. Role of renal dopamine and dopamine receptors in sodium excretion. Pharmacol Toxicol 1990;66:237-240.
80. Linares OA, Halter JH: Sympathochromaffin system activity in the elderly. J Am Geriatr Soc 1987;35:448-450.
81. Kuchel OG, Kuchel GA: Peripheral dopamine in pathophysiology of hypertension: Interaction with aging and lifestyle. Hypertension 1991;18:709-715.
82. Amenta F, Collier WL, Coppola L, De Michele M: Senescence of the peripheral dopaminergic system; in Amenta F (ed): Peripheral Dopamine Pathophysiology. Boca Raton, CRC Press, 1990, p 243.
83. Morgan DG, Finch CE: Dopaminergic changes in the basal ganglia, a generalized phenomenon of aging in mammals. Ann NY Acad Sci 1988; 515:145-152.
84. Cabrera A, van der Dijs B, Jimenez V, Guerrero H, Lechin F: Plasma neurotransmitters profile in normal subjects. 12th Latinam Congr Pharmacol 3rd Interam Congr Clin Pharmacol Ther, Caracas 1988. Arch Ven Farmacol Terap 1988;7(suppl 1):A107.
85. 2 with age. Clin Res 1991;39:226A.
86. Fukagawa WK, Bandini LG, Rowe JW, Young JB: Effect of age on renal responses to protein ingestion in man. Clin Res 1991;37:490A.
87. Garty M, Stull R, Kopin IJ, Goldstein DS. Skin color, aging, and plasma 1-dopa levels. J Auton Nerv Syst 1980;26:261-270.
88. Freedman LS, Ohuchi T, Goldstein M, Axelrod F, Fish Y, Dancis J: Changes in human serum dopamine-beta-hydroxylase activity with age. Nature 1972;236:310-314.
89. Annat G, Vincent M, Tourniaire A, Sassard J: Relationships between blood pressure and plasma renin, aldosterone and dopamine-beta-hydroxylase in the elderly. Studies in patients over 70 years of age. Gerontology 1981;27: 266-271.
90. Woods SC, Porte D Jr: Neural control of endocrine pancreas. Physiol Rev 1976;54:596-619.
91. Mannelli M, Pupilli C, Fabbri G, Musante R, De Feo ML, Franchi F, Giusti G: Endogenous dopamine (DA) and DA2 receptors: A mechanism limiting excessive sympathic-adrenal discharge in humans. J Clin Endocrinol Metab 1988;66:626-631.
92. Mercuro G, Gessa G, Rivano CA, Lai L, Cherchi A: Evidence for a dopaminergic control of sympathoadrenal catecholamine release. Am J Cardiol 1988;62:827-828.
93. Missale C, Memo M, Liberini P, Spano P: Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors. J Pharmacol Exp Ther 1988;246:1137-1143.
94. Van Loon GR, Sole MJ, Bain J, Ruse JL: Effects of bromocriptine on plasma catecholamine in normal men. Neuroendocrinology 1979;28:425-434.
95. Lipsitz LA, Pluchino FC, Wei JY, Minaker KL, Rowe JW: Cardiovascular and norepinephrine responses after meal consumption in elderly (older than 75 years) persons with postprandial hypotension and syncope. Am J Cardiol 1986;58:810-815.
96. Goldstein DS, Lake CR, Chernow B, Ziegler MG, Coleman MD, Taylor AA, Mitchell JR, Kopin IJ, Keiser HR: Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension 1983;5: 100-107.
97. Joossens JV: Sel et hypertension, dureté de l'eau et mortalité par affections cardiovasculaires. Triangle 1973;12:9-15.
98. Khaw KT, Barrett-Connor E: Increasing sensitivity of blood pressure to dietary sodium and potassium with increasing age. Am J Hypertens 1990;3:505-509.
99. Matzen SH: Neuroendocrine mechanisms during reversible hypovolaemic shock in humans with emphasis on the histaminergic and serotonergic system. Acta Physiol Scand 1995;155:1-31.
100. Senard JM, Rascol O, Durrieu G, Tran MA, Berlan M, Rascol A, Montastruc JL: Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy. Clin Neuropharmacol 1993;16:70-76.
101. Ziegler M, Lake CR, Kopin IJ: The sympathetic nervous system defect in primary orthostatic hypotension. New Engl J Med 1977; 296:293-297.
102. Polinsky RJ, Kopin IJ, Ebert MH, Weise V: Pharmacological distinction of different orthostatic hypotension syndromes. Neurology 1981;31:1-7.
103. Onrot J, Goldberg MR, Biaggioni Y, Willey RG, Hollister MS, Robertson D: Oral yohimbine in human orthostatic failure. Neurology 1987;37:215-220.
104. Grossman E, Rea RF, Hoffman A, Goldstein DS: Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 1991;260: R142-147.
105. Des Lauriers A, Wildocher D, Allilaire JF, Lecubrier Y, Simon P: Effets correcteurs de la yohimbine sur l'hypotension orthostatique induite par les antidépresseurs tricycliques. Ann Med Intern 1980;131:308-313.
106. Lechin F, van der Dijs B, Rada I, Jara H, Lechin AE, Cabrera A, Lechin ME, Jimenez V, Gomez F, Villa S, Acosta E, Arocha L: Plasma neurotransmitters and cortisol in duodenal ulcer patients: Role of stress. Dig Dis Sci 1990;35:1313-1319.
107. Lechin M, Villa S, Rada Y, Jara H, Cabrera A, Jimenez V, van der Dijs B, Lechin F: Plasma neurotransmitters profile in reflux esophagitis. 12th Latinam Congr Pharmacol 3rd Interam Congr Clin Pharmacol Ther, Caracas 1988. Arch Ven Farmacol Terap 1988; 7(suppl 1):A85.
108. Christensen NJ, Bransborg O, Lodgreen NA: Elevated plasma noradrenaline concentrations in duodenal ulcer patients are not normalized by vagotomy. J Clin Endocrinol Metab 1979;49:331-334.
109. Christensen NJ: Catecholamines in essential hypertension and duodenal ulcer. Clin Physiol 1981;1:32-37.
110. Haug TT, Svebak S, Hausken T, Wilhelmsen Y, Berstad A, Ursin H: Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 1994;56:181-186.
111. Hausken T, Svebak S, Wilhelmsen Y, Tangen T, Olafsen K, Petterson E, Hveem K, Berstad A: Low vagal and antral dysmotility in patients with functional dyspepsia. Psychosom Med 1993;55:12-22.
112. Weiner H: From simplicity to complexity (1950-1990): The case of peptic ulceration-I. Human studies. Psychosom Med 1991;53: 467-490.
113. Van Heck GL, Vingerhoets JJM, Van Hout GCM: Coping and extreme response tendency in duodenal ulcer patients. Psychosom Med 1991;53:566-575.
114. Chaudhary NA, Truelove SC: Human colonic motility: A comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable bowel syndrome I. Resting patterns of motility. Gastroenterology 1961,40:1-17.
115. Deller DJ, Wangel AG: Intestinal motility in man. A study combining the use of intraluminal pressure recording and cineradiography. Gastroenterology 1965;48:45-57.
116. Connell AM: Significance of the pressure waves of the sigmoid colon. Am J Dig Dis 1965;10:455-462.
117. Taylor Y, Darby C, Hammond P, Basu P: Is there a myoelectrical abnormality in the irritable bowel syndrome? Gut 1978;19:391-395.
118. Lechin F, van der Dijs B, Bentolila A, Peña F: Antidiarrheal effects of dihydroergotamine. J Clin Pharmacol 1977;17:339-349.
119. Christensen J: Motility of the colon; in Johnson LR (ed): Physiology of the Gastrointestinal Tract. New York, Raven Press, 1981, p 445.
120. Snape WJ Jr, Cohen S: Effect of bethanechol, gastrin-I, or cholecystokinin on myoelectric activity. Am J Physiol 1979;236:E458-463.
121. Wienbeck M, Christensen J: Effects of some drugs on electrical activity of the isolated colon of the cat. Gastroenterology 1971;61: 470-478.
122. Wangel AG, Deller DJ: Intestinal motility in man. III. Mechanisms of constipation and diarrhea with particular reference to the irritable colon syndrome. Gastroenterology 1965;48:69-84.
123. Watson WC, Sullivan SN: Hypertonicity of the cricopharyngeal sphincter: A cause of globus sensation. Lancet 1974;ii:1417-1419.
124. Horowitz L, Farrar JT: Intraluminal small intestinal pressures in normal patients and in patients with functional gastrointestinal complaints. Gastroenterology 1962;41:455-464.
125. Thompson DG, Laidlow JM, Wingate DL: Abnormal small bowel motility demonstrated by radiotelemetry in a patient with irritable colon. Lancet 1979;ii:1321-1323.
126. Gutierrez JG, Chey WY, Dinoso VP: Actions of cholecystokinin and secretin on the motor activity of the small intestine in man. Gastroenterology 1974;67:35-41.
127. Harvey RF, Read AE: Effects of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome. Lancet 1973;i:1-3.
128. Lechin F, van der Dijs B: Physiological effects of endogenous CCK on distal colon motility. Acta Gastroenterol Latinoam 1979;9:195-201.
129. Martensson HG, Zinner MJ, Jaffe BM: Effects of intraluminal perfusion with serotonin on jejunal motility. Dig Dis Sci 1986;31:811-816.
130. Jaffe BM: Prostaglandins and serotonin: Nonpeptide diarrheogenic hormones. World J Surg 1979;3:565-578.
131. Bennett A, Whitney B: A pharmacological study of the motility of the human gastrointestinal tract. Gut 1966;7:307-311.
132. McFadden D, Jaffe BM, Zinner MJ: Secretory effects of intravenous serotonin on the proximal jejunum of the awake dog. Am J Surg 1985;149:60-64.
133. Lechin F, van der Dijs B, Baez-Lechin S, Lechin A, Orozco B, Lechin M, Rada Y, Jara H, Gomez F, Cabrera A, Jimenez V, Arocha L, Leon G: Two types of irritable bowel syndrome: Pathophysiologic and pharmacological considerations. Arch Ven Farmacol Terap 1994;12:105-114.
134. King MD, Young DG, Hann IM, Patrick WJ: Carcinoid syndrome: An unusual cause of diarrhea. Arch Dis Child 1985;60:269-271.
135. Aldrich LB, Moattari AR, Vinik AI: Distinguishing features of idiopathic flushing and carcinoid syndrome. Arch Int Med 1988;148: 2614-2618.
136. Vinick AI, Thompson N, Eckhauser F, Moattari AR: Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncol 1989;28:389-402.
137. Robertson JI: Carcinoid syndrome and serotonin: Therapeutic effects of ketanserin. Cardiovasc Drugs Ther 1990;4:53-58.
138. von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM: Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 1993;329:1073-1078.
139. Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM: Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995;92:790-795.
140. Lechin F, van der Dijs B, Gomez F, Acosta E, Arocha L: Comparison between the effects of d-amphetamine and fenfluramine on distal colon motility in non-psychotic patients Res Commun Psychol Psychiatry Behav 1982;7: 411-430.
141. Lechin F, van der Dijs B, Gomez F, Arocha L, Acosta E: Effects of d-amphetamine, clonidine, and clonazepam on distal colon motility in nonpsychotic patients. Res Commun Psychol Psychiatry Behav 1982;7:385-410.
142. Lechin F, van der Dijs B: Opposite effects on human distal colon motility of two postulated alpha2-antagonists (mianserin and chlorprothixene) and one alpha2-agonist (clonidine). J Clin Pharmacol 1983;23:209-218.
143. Lechin F, van der Dijs B: The effects of dopaminergic blocking agents on distal colon motility. J Clin Pharmacol 1979,19:617-623.
144. Lechin F, van der Dijs B: Intestinal pharmacomanometry and glucose tolerance: Evidence for two antagonistic dopaminergic mechanisms in the human. Biol Psychiatry 1981;16:969-986.
145. Lechin F, van der Dijs B: Dopamine and distal colon motility. Dig Dis Sci 1979;24:86.
146. Lechin F, van der Dijs B: Colon motility and psychological traits in the irritable bowel syndrome. Dig Dis Sci 1981;26:474.
147. Lechin F, van der Dijs B: Effects of diphenylhidantoin on distal colon motility. Acta Gastroenterol Latinam 1979;9:145-152.
148. Lechin F, van der Dijs B, Gomez F, Lechin ME, Arocha L, Villa S: Biological markers employed in the assessment of central autonomic nervous system functioning: An approach to the diagnosis of some psychiatric and psychosomatic syndromes; in Lechin E, van der Dijs B (eds): Neurochemistry and Clinical Disorders: Circuitry of Some Psychiatric and Psychosomatic Syndromes. Boca Raton, CRC Press, 1989, pp 172-178.
149. Lechin F, Coll-Garcia E, van der Dijs B, Bentolila A, Peña F, Rivas C: The effects of dopaminergic blocking agents on the glucose tolerance test in six humans and six dogs. Experientia 1979;35:886-890.
150. Gordon JL, Olverman JH: 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets. Br J Clin Pharmacol 1978;62:219-226.
151. Lingjaerde O, Kildemo O: Dopamine uptake in platelets: two different low-affinity saturable mechanisms. Agents Actions 1981;11: 410-416.
152. Lechin F, van der Dijs B, Bentolila A, Peña F: Adrenergic influences on the gallbladder emptying. Am J Gastroenterol 1978;69:662-668.
153. Kamath PS, Gaisano HY, Phillips SF, Miller LJ, Charboneau JW, Brown ML, Zinsmeister AR: Abnormal gallbladder motility in irritable bowel syndrome: Evidence for target-organ defect. Am J Physiol 1991;260:G375-G376.
154. Lechin F, van der Dijs B: Adrenergic-serotonergic influences on gallbladder motility and irritable bowel syndrome. Am J Physiol 1992; 262:375-376.
155. Barnes PJ: Circulating catecholamines in asthma. Clin Physiol 1981;1:89-93.
156. Lechin AE, Villa S, Jara H, Cabrera A, Jimenez V, Guerrero H, van der Dijs B, Lechin F: Plasma neurottansmitters profile in bronchial asthma. 12th Latinam Congr Pharmacol 3rd Interam Congr Clin Pharmacol Ther, Caracas 1988. Arch Ven Farmacol Terap 1988; 7(suppl 1):A10.
157. Lechin AE, Varon J, van der Dijs B, Lechin F: Plasma catecholamines and indoleamines during attacks and remission on severe bronchial asthma: Possible role of stress. Am J Respir Crit Care Med 1994;149:A778.
158. Lechin AE, Varon J, van der Dijs B, Lechin F: Plasma neurotransmitters, blood pressure and heart rate during rest and exercise. Am J Respir Crit Care Med 1994;149:A482.
159. Larsson K, Carlens P, Bevegard S, Hjemdahl P: Sympathoadrenal responses to bronchoconstriction in asthma: An invasive and kinetic study of plasma catecholamines. Clin Sci 1995;88:439-446.
160. Lechin F, van der Dijs B, Orozco B, Lechin ME, Lechin AE: Increased free-serotonin plasma levels in symptomatic asthmatic patients. Ann Allergy Asthma Immunol, in press.
161. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M: Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995;107: 1538-1544.
162. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J: The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995;18:377-381.
163. Facchinetti F, Demyttenaere K, Fioroni L, Neri I, Genazzani AR: Psychosomatic disorders related to gynecology. Psychother Psychosom 1992;58:137-154.
164. Lechin F, van der Dijs B: Treatment of infertility with levodopa. Br Med J 1980;280:480.
165. Gonzales GF, Carrillo C: Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels. Maturitas (Ireland) 1993;17:23-29.
166. Gonzalez GF, Garcia-Hjarles M, Velasquez G: Hyperprolactinemia and hypersertoninemia: Their relationship to seminal quality. Andrologia (Germany) 1992;24:95-100.
167. Gonzalez GF, Garcia-Hjarles MA: Blood/ seminal serotonin levels in infertile men with varicocele. Arch Androl 1990;24:193-199.
168. Gonzalez GF, Garcia-Hjarles MA, Napuri R, Coyotupa J, Guerra-Garcia R: Blood serotonin levels and male infertility. Arch Androl 1989;22:85-89.
169. Ishikawa H, Takeshima H: An evaluation of blood serotonin in infertile male patients. Hinyokika Kiyo (Japan) 1984;30:1201-1205.
170. Cockett AT, Al-Juburi A, Altebarmakian V, Vergamini RF, Caldamone AA: The varicocele: New experimental and clinical data. Urology 1980;15:492-495.
171. Cockett AT, Al-Juburi A, Altebarmakian V, Vergamini RF, Caldamone AA: The varicocele: A critical analysis of experimental and clinical data. Trans Am Assoc Genitourin Surg 1979;71:47-49.
172. Saab PG, Matthews KA, Stoney CM, McDonald RH: Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine reponses to behavioral stressors. Psychophysiology 1989;26: 270-280.
173. Beitins IZ, Barkan A, Klibanski A, Kyung N, Reppert SM, Badger TM, Veldhuis J, MacArthur JW: Hormonal responses to short term fasting in postmenopausal women. J Clin Endocrinol Metab 1985;60:1120-1126.
174. Lechin ME, Jara H, Villa S, Gomez F, Cabrera A, Guerrero H, van der Dijs B, Lechin F: Plasma neurotransmitters profile in somatoform disorders. 12th Latinam Congr Pharmacol 3rd Interam Congr Clin Pharmacol Ther, Caracas 1988. Arch Ven Farmacol Terap 1988;7(suppl 1):A2.
175. Lechin F, van der Dijs B, Lechin E: The autonomic nervous system: Physiological basis of psychosomatic therapy. Barcelona, Editorial Científico-Médica, 1979, chap 2.
176. Lechin F, van der Dijs B, Amat J, Lechin ME: Noradrenergic system; in Lechin F, van der Dijs B (eds): Neurochemistry and Clinical Disorders: Circuitry of Some Psychiatric and Psychosomatic Syndromes. Boca Raton, CRC Press, 1989, pp 2-10.
177. Lechin F, van der Dijs B, Villa S, Lechin AE: Central nervous system circuitry involved in blood pressure regulation; in Lechin F, van der Dijs B (eds): Neurochemistry and Clinical Disorders: Circuitry of Some Psychiatric and Psychosomatic Syndromes. Boca Raton, CRC Press, 1989, pp 121-150.
178. Lechin F, van der Dijs B, Lechin E: The Autonomic Nervous System: Physiological Basis of Psychosomatic Therapy. Barcelona, Editorial Científico Médica, 1979, pp 65-72.
179. Lechin F, van der Dijs B, Amat J, Lechin ME: The cholinergic system; in Lechin F, van der Dijs B (eds): Neurochemistry and Clinical Disorders: Circuitry of Some Psychiatric and Psychosomatic Syndromes. Boca Raton, CRC Press, 1989, pp 14-17.
180. Lechin F, van der Dijs B, Amat J, Lechin ME: The dopaminergic system: in Lechin F, van der Dijs B (eds): Neurochemistry and Clinical Disorders: Circuitry of some psychiatric and psychosomatic syndromes. Boca Raton, CRC Press, 1989, pp 12-14.
181. Leonard BE: Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychother Psychosom 1996;65:66-75.
182. Lechin F, van der Dijs B, Amat J, Lechin ME: The serotonergic system: in Lechin F, van der Dijs B (eds): Neurochemistry and Clinical Disorders: Circuitry of Some Psychiatric and Psychosomatic Syndromes. Boca Raton, CRC Press, 1989, pp 10-12.
183. Gronstad KO, Zinner MJ, Dahlstrom A, Jaffe BM, Ahlman H: Vagal release of serotonin into gut lumen and portal circulation via separate control mechanisms. J Surg Res 1987; 43:205-210.
184. Tobe T, Izumikawa F, Sano M, Tanaka C: Release mechanisms of 5-HT in mammalian gastrointestinal tract-especially vagal release of 5-HT; in Fujita T (ed): Endocrine Gut-Pancreas. Amsterdam, Elsevier, 1976, pp 371-380.
185. Schworer H, Quyyumi AA, Brush JE, Epstein SE: Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1990;336:127-132.
186. Ireland SJ, Tyers MB: Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vague nerve. Br J Pharmacol 1987;90:229-238.
187. Hay M, Bishop VS: Effects of area postrema stimulation on neurons of the nucleus of the solitary tract. Am J Physiol 1991;260: H1359-H1363.
188. Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Oates JA: Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979;59:637-643.
189. Lechin F, van der Dijs B, Lechin ME, Lechin-Baez S, Jara H, Lechin AE, Orozco B, Rada Y, Cabrera A, Jimenez V: Effects of an oral glucose load on plasma neurotransmitters in humans: Involvement of REM sleep? Neuropsychobiology 1992;26:4-11.
190. Frankenhaeuser M: The sympathic-adrenal and pituitary-adrenal response to challenge: Comparison between the sexes: in Dembroski TM, Schmidt TH, Blümchen G (eds): Behavioral Bases of Coronary Heart Disease. New York, Karger, 1983, pp 91-105.
191. Lazarus RS: Psychological stress and coping in adaptation and illness; in Lipowsky ZJ, Lipsitt DR, Whybrow PC (eds). Psychosomatic medicine. Current Trends and Clinical Applications. New York, Oxford University Press, 1977, pp 14-26.
192. Lechin F, van der Dijs B, Jakubowicz D, Camero RE, Villa S, Lechin E, Gomez F: Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone and prolactin plasma levels in low and high intestinal tone subjects. Neuroendocrinology 1985;40:253-261.
193. Lechin F, van der Dijs B, Jakubowicz D, Camero RE, Villa S, Arocha L, Lechin AE: Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone depressed patients. Neuroendocrinology 1985;41:156-162.
194. Lechin F, van der Dijs B, Jakubowicz D, Camera RE, Lechin S, Villa S, Reinfeld B, Lechin ME: Role of stress in the exacerbation of chronic illness. Effects of clonidine administration on blood pressure, norepinephrine, cortisol, growth hormone and prolactin plasma levels. Psychoneuroendocrinology 1987; 12:117-129.
195. Schreiberg GL, Dunaieva LP: Catecholamines, system hypothalamus-hypophysis-adrenal cortex and stress: in Usdin E, Kvetnansky R, Kopin IJ (eds): Catecholamines and Stress. Oxford, Pergamon Press, 1976, p 157.
196. Lechin F, van der Dijs B, Orozco B, Lechin AE, Baez S, Lechin ME, Benaim M, Acosta E, Arocha L, Jimenez V, Leon G, Garcia Z: Plasma neurotransmitters, blood pressure and heart rate during supine resting, orthostasis and moderate exercise in severely ill patients: A model of failing to cope with stress. Psychother Psychosom 1996;355:129-136.
197. Sauerbier Y, von Mayersbach H: Circadian variation of serotonin levels in human blood. Horm Metab Res 1976;8:157-158.
198. Wirz-Justice A, Lichsteiner M, Feer H: Diurnal and seasonal variations in human platelet serotonin in man. J Neural Transm 1977;41: 7-15.
199. Lechin F, van der Dijs B, Orozco B, Baez S, Rada Y, Garcia Z, Jara H, Lechin AE, Lechin ME: Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise stress test in healthy humans before and after parasympathetic blockade with atropine. Arch Ven Farmacol Terap, in press.
200. Vesifeld IL, Vasiljiev VN, Iljicheva RF: Relationship of catecholamines, histamine and serotonin in men under different kinds of stress; in Usdin E, Kvetnansky R, Kopin IJ (eds): Catecholamines and Stress. Oxford, Pergamon Press, 1976, pp 527-528.
201. Lechin F, van der Dijs B, Orozco B, Lechin ME, Baez S, Lechin AE, Rada Y, Acosta E, Arocha L, Jimenez V, Leon G, Garcia Z: Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiatry 1995;38: 166-173.
202. Lechin F, van der Dijs B, Orozco B, Lechin AE, Baez S, Lechin ME, Rada Y, Acosta E, Arocha L, Jimenez V, Leon G, Garcia Z: Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in dysthymic depressed patients. Biol Psychiatry 1995;37: 884-891.
203. Lechin F, van der Dijs B, Vitelli-Flores G, Lechin-Baez S, Azocar J, Cabrera A, Lechin AE, Jara H, Lechin ME, Gomez F, Arocha L: Psychoneuroendocrinological and immunological parameters in cancer patients: Involvement of stress and depression. Psychoneuroendocrinology 1990;15:435-451.
204. Sifneos PE: The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973;22:255-262.